ILIUM BUTORGESIC INJECTION

País: Austrália

Língua: inglês

Origem: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Compre agora

Ingredientes ativos:

BUTORPHANOL BASE AS BUTORPHANOL TARTRATE

Disponível em:

TROY LABORATORIES PTY LTD

DCI (Denominação Comum Internacional):

butorphanol as tartrate(10mg/mL)

Forma farmacêutica:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composição:

BUTORPHANOL BASE AS BUTORPHANOL TARTRATE ALKALOID Active 10.0 mg/ml

Unidades em pacote:

10mL; 50mL

Classe:

VM - Veterinary Medicine

Fabricado por:

TROY LABORATORIES

Grupo terapêutico:

CAT | DOG | HORSE | BITCH | CASTRATE | CAT - QUEEN | CAT - TOM | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH

Área terapêutica:

ANAESTHETICS/ANALGESICS

Indicações terapêuticas:

ANALGESIC | SEDATIVE | ANTIPYRETIC | COLIC | MUSCLE RELAXANT | SEDATIVE | SPASMOLYTIC

Resumo do produto:

Poison schedule: 8; Withholding period: MEAT WITHHOLDING PERIOD (HORSES): Horses producing meat and offal for human cons umption must not be sold for slaughter e ither during or within 63 days of cessat ion of last treatment.; Host/pest details: CAT: [ANALGESIC, SEDATIVE]; DOG: [ANALGESIC, SEDATIVE]; HORSE: [ANALGESIC, SEDATIVE]; Poison schedule: 8; Withholding period: MEAT WITHOLDING PERIOD (HORSES): Do no t use in horses intended for human cons umption.; Host/pest details: CAT: [ANALGESIC, SEDATIVE]; DOG: [ANALGESIC, SEDATIVE]; HORSE: [ANALGESIC, SEDATIVE]; Poison schedule: 8; Withholding period: ; Host/pest details: CAT: [ANALGESIC, SEDATIVE]; DOG: [ANALGESIC, SEDATIVE]; HORSE: [ANALGESIC, SEDATIVE]; Analgesic and sedative for use in horses, dogs and cats.Not be administered to horses or dogs with a history of liver disease. This product should not be used in breeding horses, weanlings or foals. See RESTRAINTS, etc on Label.

Status de autorização:

Registered

Data de autorização:

2022-07-01

Folheto informativo - Bula

                                DOGS
0.1-0.3mg/kg bw (0.01-0.03mL/kg
bw) IM, SC, IV
CATS
0.1-0.4mg/kg bw. (0.01-0.04mL/kg
bw) IM, SC, IV
HORSES
0.02-0.1mg/kg bw. (0.2-
1.0mL/100kg bw) IV
MEAT WITHHOLDING PERIOD (HORSES):
DO NOT USE in horses intended for human
consumption.
FIRST AID
If poisoning occurs, contact a doctor or Poisons
Information Centre. Phone Australia 131126.
TROY LABORATORIES PTY. LIMITED
98 LONG ST SMITHFIELD, NSW 2164
AUSTRALIA
W: www.troylab.com.au
E: info@troylab.com.au
DISPOSAL
Dispose of empty container by wrapping with paper
and putting in the garbage.
STORAGE
Store below 25°C (Air conditioning). Protect
from light.
APVMA Approval No.: 63462/10ML/0809
Batch:
Expiry:
9313754310709
barcode
10mL
10mL
10mL
ACTIVE CONSTITUENT:
10mg/mL Butorphanol
(as tartrate)
ACTIVE CONSTITUENT:
10mg/mL Butorphanol
(as tartrate)
_Analgesic and sedative _
_for use in horses, _
_dogs and cats_
_Analgesic and sedative _
_for use in horses, _
_dogs and cats_
_Analgesic and sedative _
_for use in horses, dogs and cats_
CONTROLLED DRUG
POSSESSION WITHOUT AUTHORITY ILLEGAL
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
CONTROLLED DRUG
POSSESSION WITHOUT AUTHORITY ILLEGAL
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
INJECTION
INJECTION
INJECTION
INJECTION
INJECTION
INJECTION
CD0834
READ THE ENCLOSED LEAFLET BEFORE USING
THIS PRODUCT
DIRECTIONS FOR USE
RESTRAINTS
NOT TO BE USED in food producing species
of animals.
NOT TO BE USED in horses intended for human
consumption.
DOSAGE AND ADMINISTRATION
Use the contents within 90 days of first
broaching this vial. Discard the unused portion.
For animals less than 10kg bodyweight
administration by insulin syringe is recommended.
Due to the low volumes involved, care should be
taken when administering this product to animals
weighing less than 5kg.
File Name: 63462_45719_10ML_CARTON_MPL_V2
Dimensions: 31x33x67mm
Scale: A4 = 100% to scale
Date: 7th October 2009
PMS BLACK C
PMS 872 c
PRINT COLOURS
139.25
31
33
67
155
APPROVED
LABEL
Info
PEST

Verified
ACTIVE CONSTITUENT:
10mg/mL Butorphanol
                                
                                Leia o documento completo
                                
                            

Características técnicas

                                MATERIAL SAFETY DATA SHEET
PRODUCT NAME: ILIUM BUTORGESIC INJECTION
PAGE: 1 OF 5
THIS REVISION ISSUED: JULY, 2010
MATERIAL SAFETY DATA SHEET
Issued by: Troy Laboratories Australia Pty Ltd
Phone: 02 9677 9000
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
TROY LABORATORIES AUSTRALIA PTY. LTD ABN: 21 000 283 769
TEL:
(02)9677 9000
31-35 GLENDENNING ROAD
FAX:
(02) 9677 9300
GLENDENNING NSW 2761
CHEMICAL NATURE:
Butorphanol is a morphinan-type synthetic opioid. It is presented here
in water
solution.
TRADE NAME:
ILIUM BUTORGESIC INJECTION
PRODUCT CODE:
3107, 3108
PRODUCT USE:
Analgesic and sedative for use in horses, dogs and cats
CREATION DATE:
NOVEMBER, 2009
THIS VERSION ISSUED:
JULY, 2010
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S24/25. Avoid contact with skin and eyes.
SUSDP CLASSIFICATION:
S8
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
EMERGENCY OVERVIEW
PHYSICAL DESCRIPTION & COLOUR
: Clear, colourless liquid.
ODOUR:
No odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
POTENTIAL HEALTH EFFECTS
ACUTE EFFECTS:
RATS: The acute intravenous LD
50
in rats is 20 mg/kg. Test animals showed either muscle tenseness or
flaccidity
within 30 seconds after dosing. Convulsions and death followed.
MICE: The acute intravenous LD
50
in mice is 32 mg/kg. Ataxia, extreme nervousness, convulsions and
death occurred
within 1 minute after dosing. Surviving rats at this dose level
appeared clinically normal 30 minutes after receiving the
test material.
HORSES: Rapid intravenous administration of butorphanol at a dosage of
2.0 mg/kg BW (20 ti
                                
                                Leia o documento completo